Stromal COL12A1 defines a pro-invasive extracellular matrix niche in appendiceal mucinous neoplasms and pseudomyxoma peritonei
- 1University of Manchester
Abstract
Pseudomyxoma peritonei (PMP) is an uncommon peritoneal malignancy, most often arising from appendiceal mucinous neoplasms (AMNs), in which tumour progression is accompanied by extensive mucus accumulation. Although PMP is clinically dominated by peritoneal dissemination, the stromal matrix cues that support invasion and metastatic niche formation remain poorly defined. Here, we profile extracellular matrix niche from PMP patient samples, and show that AMNs and peritoneal metastases (PMs) exhibit marked ECM remodelling, including enrichment of mucins, fibrillar matrix components and stromal regulators of collagen architecture. Three-dimensional matrix models demonstrate that PMP cell invasion is strongly influenced by ECM composition, with collagen/fibronectin-rich environments promoting invasion and selected small leucine-rich proteoglycans (SLRPs) attenuating this response. Collagen organisation analysis reveals increased matrix deposition, density and alignment in metastatic lesions, consistent with development of a remodelled pro-invasive stromal niche. Among altered matrix proteins, COL12A1 is prominently upregulated in both primary and peritoneal disease and is enriched within the stromal compartment. Functional co-culture experiments further show that COL12A1-expressing cancer-associated fibroblasts (CAFs) enhance PMP cell invasion, whereas COL12A1 silencing in CAFs reduces this pro-invasive effect. These findings identify stromal COL12A1 as a key component of the PMP matrix niche and suggest that collagen XII-dependent remodelling of the tumour microenvironment may contribute may support dissemination and establishment of the metastatic disease. Together, our data indicate that human AMN and PMP have a compositionally and architecturally remodelled extracellular matrix, within which stromal COL12A1 supports CAF-driven tumour-cell invasion.
Related
- Clinicopathologic characteristics and molecular landscape for pseudomyxoma peritonei of appendiceal origin.
- Advanced Lung Cancer Inflammation Index as a Prognostic Inflammation–Nutrition Marker in Appendiceal High‐Grade Pseudomyxoma Peritonei: A 10‐Year Single‐Center Study
- Integrated Microbial Profiling Identifies Bacterial and Fungal Communities in Pseudomyxoma Peritonei Mucin.
- Evaluating the non-inferiority of HIPEC with mitomycin C 10 mg/m2 for 60 min versus HIPEC with mitomycin C 35 mg/m2 for 90 min in the treatment of pseudomyxoma peritonei from perforated epithelial mucinous tumours of the appendix (HIPEC-PMP): protocol for a single-blinded, randomised controlled trial
- Subtypes of invasive intracholecystic papillary-tubular neoplasms: a propensity score-matched Surveillance, Epidemiology, and End Results analysis.
BibTeX
@misc{upton2026stromal,
title = {{Stromal COL12A1 defines a pro-invasive extracellular matrix niche in appendiceal mucinous neoplasms and pseudomyxoma peritonei}},
author = {M. Upton and R. Nagaraju and A. Castaneda and L. Varinelli and J. Martinez-Quintanilla and M. Gariboldi and J. Barriuso and B. Chakrabarty and S. T. O'Dwyer and D. J. Thornton and O. Aziz and P. T. Caswell},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.26.761946},
url = {https://www.biorxiv.org/content/10.64898/2026.10.26.761946v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Stromal COL12A1 defines a pro-invasive extracellular matrix niche in appendiceal mucinous neoplasms and pseudomyxoma peritonei
AU - M. Upton
AU - R. Nagaraju
AU - A. Castaneda
AU - L. Varinelli
AU - J. Martinez-Quintanilla
AU - M. Gariboldi
AU - J. Barriuso
AU - B. Chakrabarty
AU - S. T. O'Dwyer
AU - D. J. Thornton
AU - O. Aziz
AU - P. T. Caswell
PY - 2026
DA - 2026/10/26
PB - bioRxiv
DO - 10.64898/2026.10.26.761946
UR - https://www.biorxiv.org/content/10.64898/2026.10.26.761946v1
AB - Pseudomyxoma peritonei (PMP) is an uncommon peritoneal malignancy, most often arising from appendiceal mucinous neoplasms (AMNs), in which tumour progression is accompanied by extensive mucus accumulation. Although PMP is clinically dominated by peritoneal dissemination, the stromal matrix cues that support invasion and metastatic niche formation remain poorly defined. Here, we profile extracellular matrix niche from PMP patient samples, and show that AMNs and peritoneal metastases (PMs) exhibit marked ECM remodelling, including enrichment of mucins, fibrillar matrix components and stromal regulators of collagen architecture. Three-dimensional matrix models demonstrate that PMP cell invasion is strongly influenced by ECM composition, with collagen/fibronectin-rich environments promoting invasion and selected small leucine-rich proteoglycans (SLRPs) attenuating this response. Collagen organisation analysis reveals increased matrix deposition, density and alignment in metastatic lesions, consistent with development of a remodelled pro-invasive stromal niche. Among altered matrix proteins, COL12A1 is prominently upregulated in both primary and peritoneal disease and is enriched within the stromal compartment. Functional co-culture experiments further show that COL12A1-expressing cancer-associated fibroblasts (CAFs) enhance PMP cell invasion, whereas COL12A1 silencing in CAFs reduces this pro-invasive effect. These findings identify stromal COL12A1 as a key component of the PMP matrix niche and suggest that collagen XII-dependent remodelling of the tumour microenvironment may contribute may support dissemination and establishment of the metastatic disease. Together, our data indicate that human AMN and PMP have a compositionally and architecturally remodelled extracellular matrix, within which stromal COL12A1 supports CAF-driven tumour-cell invasion.
ER -